| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/30/2004 | EP1432439A2 Means for improving immune response |
| 06/30/2004 | EP1432438A2 Use of rank antagonists to treat cancer |
| 06/30/2004 | EP1432433A2 Antagonists |
| 06/30/2004 | EP1432432A2 A cancer treatment system |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | EP1383380A4 Fizz1 for metabolism regulation |
| 06/30/2004 | EP1235919B1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 06/30/2004 | EP1231831A4 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 06/30/2004 | EP1147415A4 Method and kit for extracting prion protein |
| 06/30/2004 | EP1112366B1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 06/30/2004 | EP1054688B1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
| 06/30/2004 | EP1032418B1 Compact epstein-barr virus replicons |
| 06/30/2004 | EP1007712A4 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 06/30/2004 | EP1007637B1 Methods for increasing the efficiency of recombinant aav product |
| 06/30/2004 | EP0975667A4 METHODS OF DIAGNOSING CLINICAL SUBTYPES OF CROHN'S DISEASE WITH CHARACTERISTIC RESPONSIVENESS TO ANTI-Th1 CYTOKINE THERAPY |
| 06/30/2004 | EP0925554B1 Method and computer program for analyzing images |
| 06/30/2004 | EP0915902A4 Transgenic animals expressing artificial epitope-tagged proteins |
| 06/30/2004 | EP0914419B1 Transgenic mice capable of expressing leukemia inhibitory factor |
| 06/30/2004 | EP0862628B1 Receptor and nucleic acid molecule encoding said receptor |
| 06/30/2004 | EP0851876B1 Antisecretory factor peptides regulating pathological permeability changes |
| 06/30/2004 | EP0848756B1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 06/30/2004 | EP0815125B1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES |
| 06/30/2004 | EP0766742B1 Regulated expression of heterologous genes in plants and transgenic fruit with a modified ripening phenotype |
| 06/30/2004 | EP0726311B1 Process for preparing human activated protein c |
| 06/30/2004 | EP0686161B1 Novel human beta2 integrin alpha subunit |
| 06/30/2004 | EP0633939B1 Nisins |
| 06/30/2004 | EP0584167B1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 06/30/2004 | EP0564532B1 Polypeptides derived from proteins of the hepatitis c virus |
| 06/30/2004 | EP0527788B1 Hepatitis c virus protease |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509336A Process for producing peptide |
| 06/30/2004 | CN1509333A Novel neurotrophic factors |
| 06/30/2004 | CN1509332A Inflammatory inhibiting factor Fwa116 |
| 06/30/2004 | CN1509328A Use of opg ligand to modulate immune response |
| 06/30/2004 | CN1509294A High density lipoprotein-reactive peptides |
| 06/30/2004 | CN1509293A Expression technology for proteins containing hybrid isotype antibody moiety |
| 06/30/2004 | CN1508253A Hybrid expression of Neisseria protein |
| 06/30/2004 | CN1508251A Malignant malarial parasite msra-3 gene, protein product and use thereof |
| 06/30/2004 | CN1508250A Malignant malarial parasite msra-2 gene, protein product and use thereof |
| 06/30/2004 | CN1508249A Maiignant malarial parasite msra-1 gene, protein product and use thereof |
| 06/30/2004 | CN1508154A Method for preparing injection collagen, and product and use thereof |
| 06/30/2004 | CN1508153A Gonadotropin-releasing hormone juxtaposition dimer-egg albumin preparing method |
| 06/30/2004 | CN1508151A Gclq receptor, HIV-laplzo area jointed with same and relative peptide and target-directional antibody |
| 06/30/2004 | CN1508142A Human Testicular specific gene VCX-8r and VCY coding protein biological function |
| 06/30/2004 | CN1155714C Antifungal proteins, DNA coding therefore, and hosts incorporating same |
| 06/30/2004 | CN1155710C Recombinant herpesvirus with the use of gB Gene promoter |
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155707C Vaccines for plague |
| 06/30/2004 | CN1155705C Genetic modified encoded snowderop agglutinant DNA sequence and aphid-resisting, transgenic plant |
| 06/30/2004 | CN1155620C Thioether conjugates |
| 06/30/2004 | CN1155618C PEG-interferon conjugates |
| 06/30/2004 | CN1155617C Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 06/30/2004 | CN1155616C Human protein with cancer cell growth promoting function and its coding sequence |
| 06/30/2004 | CN1155615C Human protein with cancer cell growth suppressing function and its coding sequence |
| 06/30/2004 | CN1155614C Human protein with cancer cell growth suppressing function and its coding sequence |
| 06/30/2004 | CN1155613C Human tumor associated gene in 1-zone 3-band 3-subband of short arm of human chromosome No. 17 and its coding protein |
| 06/30/2004 | CN1155407C Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine |
| 06/30/2004 | CN1155402C Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 06/29/2004 | US6756524 Nucleotide sequences coding polypeptide for use in controling fruit size and cell division in plants |
| 06/29/2004 | US6756493 A polypeptide of neisseria spp, e.g, of neisseria gonorrhoeae |
| 06/29/2004 | US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome |
| 06/29/2004 | US6756484 IGF-I purification process |
| 06/29/2004 | US6756483 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 06/29/2004 | US6756482 Purified human activin and process for producing the same |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756479 Isolated polypeptide of given sequence; use in differentiation of monocytes and as a anti-proliferative agent for lung tumor cells |
| 06/29/2004 | US6756478 Polypeptide for use in diagnosis and treatment of infections |
| 06/29/2004 | US6756477 Comprise breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions |
| 06/29/2004 | US6756410 Contacting cell with compound that activates extracellular signal regulated kinase, p42/44mapk, wherein activation of kinase results in induction of low density lipoprotein receptor expression; treatment of hypercholesterolemia |
| 06/29/2004 | US6756358 Promoter for chondrocyte proliferation agent; administering hepatocyte growth factor |
| 06/29/2004 | US6756357 Variants of human ciliary neurotrophic factor (hCNTF) |
| 06/29/2004 | US6756356 For inhibiting functions such as cell adhesion and the formation of tissue permeability barriers |
| 06/29/2004 | US6756355 HMGI proteins in cancer and obesity |
| 06/29/2004 | US6756228 Atherosclerosis susceptibility gene locus 1 (Athsq1) and atherosclerosis susceptibility gene locus 2 (Athsq2) |
| 06/29/2004 | US6756227 Used as prophylactic and/or therapeutic agents and polypeptides in medicine |
| 06/29/2004 | US6756215 Tgf- beta family protein function while also having an additional functionality conveyed by the addition of a functionalizing peptide domain; for diagnosis of various conditions including cancer and kidney diseases |
| 06/29/2004 | US6756214 Protein zlmda33 |
| 06/29/2004 | US6756213 Nucleic acid encoding retinoic acid receptor |
| 06/29/2004 | US6756212 Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof |
| 06/29/2004 | US6756211 Neutropohil inhibitors |
| 06/29/2004 | US6756206 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
| 06/29/2004 | US6756205 Vasoactive peptide for use in the treatment of inflammtion, congestive heart failure, migraines, diabetes and sepsis |
| 06/29/2004 | US6756203 Assays for compounds that modulate rhadino virus LANA action in trans on a unit of rhadino virus DNA to mediate efficient episome persistence |
| 06/29/2004 | US6756201 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 06/29/2004 | US6756199 Used for the synthesis of both predefined and random sequence peptide nucleic acid oligomers |
| 06/29/2004 | US6756196 Diagnosis, screening and therapy |
| 06/29/2004 | US6756043 For diagnosing taeniasis (pork tapeworm) |
| 06/29/2004 | US6756042 Salmonella vaccine; immunogenicity; reduced possibility of strain revertion to reactive form; safe; limited side effects |
| 06/29/2004 | US6756039 Fusion protein nanostructures |
| 06/29/2004 | US6756038 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 06/29/2004 | US6756036 Methods for treating cancer using PSCA antibodies and fragments thereof |
| 06/29/2004 | CA2410699C Methods and compositions for inhibiting angiogenesis |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2242347C A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
| 06/29/2004 | CA2038669C Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/27/2004 | CA2451588A1 Protein having active sulfate transporter activity and method for detecting canceration of tissue |
| 06/24/2004 | WO2004053499A1 Fluorescent indicator using fret |
| 06/24/2004 | WO2004053158A1 Method and kit for detecting a risk for diabetes or a metabolic syndrome |